25.08.2010 • NewsIranLyondellBasellWall Street Journal

Lyondellbasell to End Iran Operations

Specialty chemicals giant Lyondellbasell Industries will end its operations in Iran to avoid penalties the U.S. could soon impose on companies for violating trade sanctions, the Wall Street Journal said. Lyondell's board approved the decision to end its Iranian operations in early August after months of deliberation, David Harpole, a spokesman for Lyondellbasell, told the Journal.

The Dutch-based company's move will end licensing of its proprietary technology and services to Iranian petrochemical companies, the paper said. Harpole told the paper the move would be "immaterial" to Lyondellbasell's overall operations.

The mounting pressure over sanctions played a decisive role in the board's decision to halt its Iranian operations, Harpole told the Journal. Lyondellbasell, which was weighed down by debt previously, emerged out of bankruptcy protection in April.

The company plans to list 566 million shares on the New York Stock Exchange any day to revamp its capital base and help fund growth plans, according to Harpole.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.